Basic information Safety Supplier Related

1-Methyl-1H-indazole-5-carbaldehyde

Basic information Safety Supplier Related

1-Methyl-1H-indazole-5-carbaldehyde Basic information

Product Name:
1-Methyl-1H-indazole-5-carbaldehyde
Synonyms:
  • 1-Methyl-1H-indazole-5-carbaldehyde
  • 1-methylindazole-5-carbaldehyde
  • 1-Methyl-1H-indazole-5-carboxaldehyde
  • 5-Formyl-1-methyl-1H-indazole
  • 1H-Indazole-5-carboxaldehyde, 1-methyl-
  • 1-Methyl-1H-indazol-5-carbaldehyde
CAS:
872607-89-1
MF:
C9H8N2O
MW:
160.17
Product Categories:
  • Building Blocks
  • Indazole
Mol File:
872607-89-1.mol
More
Less

1-Methyl-1H-indazole-5-carbaldehyde Chemical Properties

Boiling point:
311.8±15.0 °C(Predicted)
Density 
1.21±0.1 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
0.47±0.30(Predicted)
form 
powder
color 
Yellow
CAS DataBase Reference
872607-89-1
More
Less

Safety Information

HS Code 
2933998090
More
Less

1-Methyl-1H-indazole-5-carbaldehyde Usage And Synthesis

Synthesis

465529-57-1

68-12-2

872607-89-1

1. 2.0 M tetrahydrofuran solution of n-butylmagnesium chloride (3.05 mL) was added to toluene (20 mL) under nitrogen protection and cooled to -10 °C. 2. 1.6 M hexane solution of n-butyllithium (7.63 mL) was slowly added to the above solution, keeping the reaction mixture stirred at -10 °C for 1 hour. 3. The reaction mixture was further cooled to -30 °C, then a tetrahydrofuran solution (10 mL) of 5-bromo-1-methyl-1H-indazole (2.35 g) was added. 4. The reaction mixture was slowly warmed to -10 °C and stirring was continued at this temperature for 1 hour. 5. N,N-dimethylformamide (5 mL) was added and the reaction was kept stirring at -10 °C for 1 hour. 6. the reaction was quenched with 2 N hydrochloric acid (20 mL) and the reaction mixture was allowed to warm slowly to room temperature. 7. After 30 minutes, the reaction mixture was alkalized with saturated aqueous sodium bicarbonate and then extracted with ethyl acetate (2 x 80 mL). 8. The organic phases were combined and washed sequentially with saturated sodium bicarbonate solution (2 x 100 mL), 10% aqueous lithium chloride solution (2 x 100 mL) and brine. 9. The organic phase was dried with anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. 10. The residue was purified by column chromatography on silica gel (120 g silica gel, eluent 10-30% ethyl acetate in cyclohexane solution). 11. The fractions containing the target product were combined and concentrated under reduced pressure to give 1-methyl-1H-indazole-5-carbaldehyde (1.43 g, 80% yield) as a white solid. 12. HPLC analysis: retention time Rt = 2.2 min (gradient 1); MS analysis: m/z [M + H]+ = 161 (gradient 1).

References

[1] Patent: WO2006/400, 2006, A1. Location in patent: Page/Page column 14
[2] Patent: WO2006/759, 2006, A1. Location in patent: Page/Page column 22-23
[3] Patent: WO2011/18454, 2011, A1. Location in patent: Page/Page column 61
[4] Patent: WO2011/20861, 2011, A1. Location in patent: Page/Page column 59

1-Methyl-1H-indazole-5-carbaldehydeSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Tetranov Biopharm
Tel
13526569071
Email
sales@leadmedpharm.com
ZEROSCHEM.CO.,LTD.
Tel
10-61256048 13810278579
Email
sales@zeroschem.com
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Email
info@chemlin.com.cn
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com